Results 161 to 170 of about 2,712,257 (268)

Celebrating 20 years of open access publishing at BMC Musculoskeletal Disorders. [PDF]

BMC Musculoskelet Disord, 2020
Fitzpatrick CM, Athwal A.
europepmc   +1 more source

Differential expression of cancer‐related genes supports prediction of poor response to first‐line treatments in T‐ALL pediatric patients with high minimal residual disease

Molecular Oncology, EarlyView.
In the present work, we have identified a transcriptional signature based on the differential expression of six genes (BCL2&MAST4, HSH2D&LAT2, METRN&PITPNM2) that would facilitate the early detection of T‐cell acute lymphoblastic leukemia (T‐ALL) patients prone to a poor treatment response and could be implemented at diagnosis, along with other risk ...
Antonio Lahera, Laura Vela‐Martín, Pablo Fernández‐Navarro, José Luis López‐Lorenzo, Javier Cornago, Pilar Llamas, Eduardo Pérez‐Gómez, José Luis Marín‐Rubio, Manuel Fresno, Javier Santos, José Fernández‐Piqueras, María Villa‐Morales   +11 more
wiley   +1 more source

Promoting awareness of open access publishing in speech-language therapy and audiology: Lessons from multilingual language assessment research. [PDF]

S Afr J Commun Disord
Bornman J, Bortz M, Edwards A, Louw B, Van der Linde J.   +4 more
europepmc   +1 more source

CCDC80 suppresses high‐grade serous ovarian cancer migration via negative regulation of B7‐H3

Molecular Oncology, EarlyView.
PAX8 is a lineage‐specific master regulator of transcription in high‐grade serous ovarian cancer (HGSC) progression. We show for the first time that PAX8 facilitates proliferation and metastasis by repressing the cell autonomous tumor suppressor CCDC80 and inducing B7‐H3 expression.
Aya Saleh, Nitzan Medina‐Itzhaki, Milena Chekov, Eden Gal‐Swisa, Roba Gabesh‐Wahabi, Inbar Savyon, Inna Naroditsky, Hilary A. Kenny, Basem Fares, Lina Korsensky, Einav Girsh, Liron Berger, Ruth Perets   +12 more
wiley   +1 more source

Editorial: on open access publishing

Suomen Antropologi, 2018
Andrew Graan, Elina Hartikainen, Timo Kallinen, Ville Laakkonen, Tuomas Tammisto, Pekka Tuominen, Matti Eräsaari   +6 more
doaj   +1 more source

Variability in article processing charges of open-access publishing across medical specialties. [PDF]

PLoS One
Tocco EG, Mayhew MM, Mercante MG, Kuchimanchi N, Moheb ME, Shen C, Tsung A, Witt RG.   +7 more
europepmc   +1 more source

Project DEAL - Germany is leading the way in the transition to open access publishing. [PDF]

J Appl Clin Med Phys, 2020
Mills M.
europepmc   +1 more source

KDM7A and KDM1A inhibition suppresses tumour promoting pathways in prostate cancer

Molecular Oncology, EarlyView.
Treatment resistance is a major challenge for patients with advanced prostate cancer. This study examined an alternative approach to target the major prostate cancer‐promoting pathway by targeting epigenetic factors, whose levels are higher in tumours.
Jennie N Jeyapalan, Veronika M Metzler, Simone de Brot, Corinne L Woodcock, Anna E Harris, Jennifer Lothion‐Roy, Emeli M Nilsson, Atara Ntekim, Michael S Toss, Jenny L Persson, Francesca Khani, Brian D Robinson, Lorraine J Gudas, Emad Rakha, David M Heery, Catrin S Rutland, Nigel P Mongan   +16 more
wiley   +1 more source

Hurdles to open access publishing faced by authors: a scoping literature review from 2004 to 2023. [PDF]

R Soc Open Sci
Kaliuzhna N, Aydin Z, Müller P, Hauschke C.   +3 more
europepmc   +1 more source

Publishing at any cost: a cross-sectional study of the amount that medical researchers spend on open access publishing each year. [PDF]

BMJ Open, 2021
Ellingson MK, Shi X, Skydel JJ, Nyhan K, Lehman R, Ross JS, Wallach JD.   +6 more
europepmc   +1 more source